Mast cells are important modifiers of autoimmune disease: With so much evidence, why is there controversy?
There is abundant evidence that mast cells are active participants in events that mediate tissue damage in autoimmune disease. Disease-associated increases in mast cell numbers accompanied by mast cell degranulation and elaboration of numerous mast cell mediators at sites of inflammation are commonl...
Main Authors: | Melissa Ann Brown, Julianne K Hatfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00147/full |
Similar Items
-
The exon-skipping oligonucleotide, KitStop, depletes tissue-resident mast cells in vivo to ameliorate anaphylaxis
by: Barry A. Hedgespeth, et al.
Published: (2023-01-01) -
Type II mast cells in mast cell leukemia: Uncommon yet clinically significant
by: Constance P. Chen, et al.
Published: (2024-04-01) -
Mast Cells and Basophills : development, activation and roles in allergic/autoimmune disease /
by: Novartis Foundation
Published: (2005) -
Mast Cells Retard Tumor Growth in Ovarian Cancer: Insights from a Mouse Model
by: Nicole Meyer, et al.
Published: (2023-08-01) -
Role of Mast Cells in Progression of Oral Epithelial Dysplasia
by: Shikha Saxena; Priyanka Singh; Akshay Bhargava; Krishna Sireesha Sundaragiri; Chandni Shekhawat; Bharat Sankhla
Published: (2023-07-01)